DOI: 10.25881/BPNMSC.2020.85.39.021

Авторы

Азизов С.Н., Коженов А.Т., Панин Д.В., Чрагян В.А., Мелехина Ю.В., Некрасова А.Н., Мусаев О.Г.

ФГБУ Федеральный центр сердечно-сосудистой хирургии им С.Г. Суханова Минздрава России, Пермь

Аннотация

Обзор литературы посвящён оценке эффективности и безопасности транскатетерных методов абляции. Рассмотрены и оценены преимущества и недостатки каждой из этих методик. Детально рассмотрены результаты крупных исследований посвященных использованию катетеров с датчиком давления «катетер-ткань» и криобаллона второй генерации в лечении пароксизмальной и персистирующей форм ФП. Проанализированы актуальные проблемы низкой эффективности лечения персистирующей формы ФП, и рассмотрены возможные пути ее повышения.

Ключевые слова: фибрилляция предсердий, радиочастотная абляция, криобаллонная аблация, радиочастотный катетер с датчиком давления «катетер-ткань».

Список литературы

1. Calkins H, Reynolds MR, Spector P, et al. Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses. Circ Arrhythm Electrophysiol. 2009;2(4):349–361. doi: 10.1161/CIRCEP.108.824789.

2. Oral H, Scharf C, Chugh A, et al. Catheter ablation for paroxysmal atrial fibrillation segmental pulmonary vein ostial ablation versus left atrial ablation. Circulation. 2003;108(19):2355–2360. doi: 10.1161/01.CIR.0000095796.45180.88.

3. Santangeli P, Marchlinski FE. Techniques for the provocation, localization, and ablation of nonpulmonary vein triggers for atrial fibrillation. Heart Rhythm. 2017;14 (7):1087–1096. doi: 10.1016/j.hrthm.2017.02.030.

4. Pappone C, Augello G, Sala S, et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. J Am Coll Cardiol. 2006;48(11):2340–2347. doi: 10.1016/j.jacc.2006.08.037.

5. Haissaguerre M, Jais P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. New Engl J Med. 1998;339 (10):659–666. doi: 10.1056/NEJM199809033391003.

6. Calkins H, Kuck KH, Cappato R, et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS).Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society. Heart Rhythm. 2012;9(4):632–696. doi: 10.1016/j.hrthm.2011.12.016.

7. Kuck KH, Brugada J, Furnkranz A, et al. Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. New Engl J Med. 2016;374(23):2235–2245. doi: 10.1056/NEJMoa1602014.

8. Thomas SP, Aggarwal G, Boyd AC, et al. A comparison of open-irrigated and non-irrigated tip catheter ablation for pulmonary vein isolation. Europace. 2004;6(4):330–335. doi: 10.1016/j.eupc.2004.03.001.

9. Tan AY, Li H, Wachsmann-Hogiu S, et al. Autonomic innervation and segmental muscular disconnections at the human pulmonary vein-atrial junction: implications for catheter ablation of atrial-pulmonary vein junction. J Am Col Cardiol. 2006;48(1):132–143. doi: 10.1016/j.jacc.2006.02.054.

10. Ouyang F, Tilz R, Chun J, et al. Long-term results of catheter ablation in paroxysmal atrial fibrillation: lessons from a 5-year follow-up. Circulation. 2010;122(23): 2368–2377. doi: 10.1161/CIRCULATIONAHA.110.946806.

11. Parkash R, Verma A, Tang AS. Persistent atrial fibrillation: current approach and controversies. Curr Opin Cardiol. 2010;25(1):1–7. doi: 10.1097/HCO.0b013e3283336d52.

12. Cappato R, Calkins H, Chen SA, et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol. 2010;3(1):32–38. doi: 10.1161/CIRCEP.109.859116.

13. Ouyang F, Antz M, Ernst S, et al. Recovered pulmonary vein conduction as a dominant factor for recurrent atrial tachyarrhythmias after complete circular isolation of the pulmonary veins: lessons from double Lasso technique. Circulation. 2005; 111(2):127–135. doi: 10.1161/01.CIR.0000151289.73085.36.

14. Natale A, Reddy VY, Monir G, et al. Paroxysmal AF catheter ablation with a contact force sensing catheter: results of the prospective, multicenter SMART-AF trial. J Am Col Cardiol. 2014;64(7):647–656. doi: 10.1016/j.jacc.2014.04.072.

15. Thiagalingam A, D’Avila A, Foley L, et al. Importance of catheter contact force during irrigated radiofrequency ablation: evaluation in a porcine ex vivo model using a force-sensing catheter. J Cardiovasc Electrophysiol. 2010;21(7):806–811. doi: 10.1111/j.1540-8167.2009.01693.x.

16. Lin H, Chen YH, Hou JW, et al. Role of contact force guided radiofrequency catheter ablation for treatment of atrial fibrillation: a systematic review and meta-analysis. J Cardiovasc Electrophysiol. 2017;28(9):994–1005. doi: 10.1111/jce.13264.

17. Andrade JG, Khairy P, Guerra PG, et al. Efficacy and safety of cryoballoon ablation for atrial fibrillation: a systematic review of published studies. Heart Rhythm. 2011;8(9):1444–1451. doi: 10.1016/j.hrthm.2011.03.050.

18. Furnkranz A, Chun KR, Nuyens D, et al. Characterization of conduction recovery after pulmonary vein isolation using the “single big cryoballoon” technique. Heart Rhythm. 2010;7(2):184–190. doi: 10.1016/j.hrthm.2009.10.038.

19. Chun KR, Furnkranz A, Koster I, et al. Two versus one repeat freeze-thaw cycle(s) after cryoballoon pulmonary vein isolation: the alster extra pilot study. J Cardiovasc Electrophysiol. 2012;23(8):814–819. doi: 10.1111/j.1540-8167. 2012.02315.x.

20. Stockigt F, Schrickel JW, Andrie R, ickfett L. Atrioesophageal fistula after cryoballoon pulmonary vein isolation. J Cardiovasc Electrophysiol. 2012;23(11): 1254–1257. doi: 10.1111/j.1540-8167.2012.02324.x.

21. Furnkranz A, Bordignon S, Schmidt B, et al. Improved procedural efficacy of pulmonary vein isolation using the novel second-generation cryoballoon. J Cardiovasc Electrophysiol. 2013;24(5):492–497. doi: 10.1111/jce.12082.

22. Lemes C, Wissner E, Lin T, et al. One-year clinical outcome after pulmonary vein isolation in persistent atrial fibrillation using the second-generation 28 mm cryoballoon: a retrospective analysis. Europace. 2016;18(2):201–205. doi: 10.1093/europace/euv092.

23. Ciconte G, Ottaviano L, de Asmundis C, et al. Pulmonary vein isolation as index procedure for persistent atrial fibrillation: one-year clinical outcome after ablation using the second-generation cryoballoon. Heart Rhythm. 2015;12(1):60–66. doi: 10.1016/j.hrthm.2014.09.063.

24. Koektuerk B, Yorgun H, Hengeoez O, et al. Cryoballoon ablation for pulmonary vein isolation in patients with persistent atrial fibrillation: one-year outcome using second generation cryoballoon. Circ Arrhythm Electrophysiol. 2015;8(5):1073–1079. doi: 10.1161/CIRCEP.115.002776.

25. Metzner A, Reissmann B, Rausch P, et al. One-year clinical outcome after pulmonary vein isolation using the second-generation 28-mm cryoballoon. Circ Arrhythm Electrophysiol. 2014;7(2):288–292. doi: 10.1161/CIRCEP.114.001473.

26. Curnis A, Salghetti F, Cerini M, et al. Efficacy of second-generation cryoballoon ablation in paroxysmal and persistent atrial fibrillation patients. J Cardiovasc Med (Hagerstown). 2017;18(9):655–662. doi: 10.2459/JCM.0000000000000542.

27. Omran, H, Gutleben KJ, Molatta S, et al. Second generation cryoballoon ablation for persistent atrial fibrillation: an updated meta-analysis. Clin Res Cardiol. 2017; 107(2):182–192. doi: 10.1007/s00392-017-1171-5.

28. Metzner A, Rausch P, Lemes C, et al. The incidence of phrenic nerve injury during pulmonary vein isolation using the second-generation 28 mm cryoballoon. J Cardiovasc Electrophysiol. 2014;25(5):466–470. doi: 10.1111/jce.12358.

29. Furnkranz A, Bordignon S, Schmidt B, et al. Luminal esophageal temperature predicts esophageal lesions after second generation cryoballoon pulmonary vein isolation. Heart Rhythm. 2013;10(6):789–793. doi: 10.1016/j.hrthm.2013.02.021.

30. Cox JL, Schuessler RB, D’Agostino HJ Jr, et al. The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure. J Thorac Cardiovasc Surg. 1991;101(4):569–583.

31. Albåge A, Johansson B, Kennebäck G, et al. Long-term follow-up of cardiac rhythm in 320 patients after the cox- maze III procedure for atrial fibrillation. Ann Thorac Surg. 2016;101(4):1443–1449. doi: 10.1016/j.athoracsur.2015.09.066.

32. Wolf RK, Schneeberger EW, Osterday R, et al. Videoassisted bilateral pulmonary vein isolation and left atrial appendage exclusion for atrial fibrillation. J Thorac Cardiovasc Surg. 2005;130(3):797–802. doi: 10.1016/j.jtcvs.2005.03.041.

33. Huffman MD, Karmali KN, Berendsen MA, et al. Concomitant atrial fibrillation surgery for people undergoing cardiac surgery. Cochrane Database Syst Rev. 2016; (8):CD011814. doi: 10.1002/14651858.CD011814.pub2.

34. Kearney K, Stephenson R, Phan K, et al. A systematic review of surgical ablation versus catheter ablation for atrial fibrillation. Ann Cardiothorac Surg. 2014;3(1):15–29. 10.3978/j.issn.2225-319X.2014.01.03.

35. Vroomen M, Pison L. Hybrid ablation for atrial fibrillation: a systematic review. J Interv Card Electrophysiol. 2016;47(3):265–274. doi: 10.1007/s10840-016-0183-9.

36. Nyong J, Amit G, Adler AJ, et al. Efficacy and safety of ablation for people with non-paroxysmal atrial fibrillation. Cochrane Database Syst Rev. 2016;(11):CD012088. doi: 10.1002/14651858.CD012088.pub2.

37. Han SW, Shin SY, Im SI, et al. Does the amount of atrial mass reduction improve clinical outcomes after radiofrequency catheter ablation for long-standing persistent atrial fibrillation? Comparison between linear ablation and defragmentation. Int J Cardiol. 2014;171(1):37–43. doi: 10.1016/j.ijcard.2013.11.041.

38. Tamborero D, Mont L, Berruezo A, et al. Left atrial posterior wall isolation does not improve the outcome of circumferential pulmonary vein ablation for atrial fibrillation: a prospective randomized study. Circ Arrhythm Electrophysiol. 2009;2(1):35–40. doi: 10.1161/CIRCEP.108.797944.

39. Wynn GJ, Panikker S, Morgan M, et al. Biatrial linear ablation in sustained nonpermanent AF: results of the substrate modification with ablation and аntiarrhythmic drugs in nonpermanent atrial fibrillation (SMAN-PAF) trial. Heart Rhythm. 2016;13 (2):399–406. doi: 10.1016/j.hrthm.2015.10.006.

40. Narayan SM, Baykaner T, Clopton P, et al. Ablation of rotor and focal sources reduces late recurrence of atrial fibrillation compared with trigger ablation alone: extended follow-up of the CONFIRM trial (conventional ablation for atrial fibrillation with or without focal impulse and rotor modulation). J Am Col Cardiol. 2014;63(17):1761–1768. doi: 10.1016/j.jacc.2014.02.543.

41. Lim HS, Hocini M, Dubois R, et al. Complexity and distribution of drivers in relation to duration of persistent atrial fibrillation. J Am Col Cardiol. 2017;69(10): 1257–1269. doi: 10.1016/j.jacc.2017.01.014.

42. Jourda F, Providencia R, Marijon E, et al. Contact-force guided radiofrequency vs. second-generation balloon cryotherapy for pulmonary vein isolation in patients with paroxysmal atrial fibrillation-a prospective evaluation. Europace. 2015;17(2): 225–231. doi: 10.1093/europace/euu215.

43. Buiatti A, Olshausen G, Barthel P, et al. Cryoballoon vs. radiofrequency ablation for paroxysmal atrial fibrillation: an updated meta-analysis of randomized and observational studies. Europace. 2017;19(3):378–384. doi: 10.1093/europace/euw262.

44. Furnkranz A, Bordignon S, Schmidt B, et al. Incidence and characteristics of phrenic nerve palsy following pulmonary vein isolation with the second-generation as compared with the first-generation cryoballoon in 360 consecutive patients. Europace. 2015;17(4):574–578. doi: 10.1093/europace/euu320.

45. Mugnai G, Sieira J, Ciconte G, et al. One year incidence of atrial septal defect after PV isolation: a comparison between conventional radiofrequency and cryoballoon ablation. Pacing Clin Electrophysiol. 2015;38(9):1049–1057. doi: 10.1111/ pace.12663.

46. Aryana A, Singh SM, Kowalski M, et al. Acute and long-term outcomes of catheter ablation of atrial fibrillation using the second-generation cryoballoon versus open-irrigated radiofrequency: a multicenter experience. J Cardiovasc Electrophysiol. 2015;26(8):832–839. doi: 10.1111/jce.12695.

47. Aryana A, Singh SM, Mugnai G, et al. Pulmonary vein reconnection following catheter ablation of atrial fibrillation using the second-generation cryoballoon versus open-irrigated radiofrequency: results of a multicenter analysis. J Interv Card Electrophysiol. 2016;47(3):341–348. doi: 10.1007/s10840-016-0172-z.

48. Vogler J, Willems S, Sultan A, et al. Pulmonary vein isolation versus defragmentation: the CHASE-AF clinical trial. J Am Col Cardiol. 2015;66(24):2743–2752. doi: 10.1016/j.jacc.2015.09.088.

49. Sommer P, Kircher S, Rolf S, et al. Successful repeat catheter ablation of recurrent longstanding persistent atrial fibrillation with rotor elimination as the procedural endpoint: a case series. J Cardiovasc Electrophysiol. 2016;27(3):274–280. doi: 10.1111/jce.12874.